Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

479 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment.
Scandura G, Giallongo C, Puglisi F, Romano A, Parrinello NL, Zuppelli T, Longhitano L, Giallongo S, Di Rosa M, Musumeci G, Motterlini R, Foresti R, Palumbo GA, Li Volti G, Di Raimondo F, Tibullo D. Scandura G, et al. Among authors: puglisi f. Antioxidants (Basel). 2022 Apr 12;11(4):767. doi: 10.3390/antiox11040767. Antioxidants (Basel). 2022. PMID: 35453452 Free PMC article.
Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma Cells.
Giallongo C, Tibullo D, Puglisi F, Barbato A, Vicario N, Cambria D, Parrinello NL, Romano A, Conticello C, Forte S, Parenti R, Amorini AM, Lazzarino G, Li Volti G, Palumbo GA, Di Raimondo F. Giallongo C, et al. Among authors: puglisi f. Cancers (Basel). 2020 Jul 22;12(8):1999. doi: 10.3390/cancers12081999. Cancers (Basel). 2020. PMID: 32707760 Free PMC article.
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy.
Romano A, Parrinello NL, La Cava P, Tibullo D, Giallongo C, Camiolo G, Puglisi F, Parisi M, Pirosa MC, Martino E, Conticello C, Palumbo GA, Di Raimondo F. Romano A, et al. Among authors: puglisi f. Expert Rev Mol Diagn. 2018 Jul;18(7):675-683. doi: 10.1080/14737159.2018.1470929. Epub 2018 May 3. Expert Rev Mol Diagn. 2018. PMID: 29707981
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma.
Giallongo C, Tibullo D, Camiolo G, Parrinello NL, Romano A, Puglisi F, Barbato A, Conticello C, Lupo G, Anfuso CD, Lazzarino G, Li Volti G, Palumbo GA, Di Raimondo F. Giallongo C, et al. Among authors: puglisi f. Cell Death Dis. 2019 Sep 20;10(10):704. doi: 10.1038/s41419-019-1959-5. Cell Death Dis. 2019. PMID: 31541083 Free PMC article.
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma.
Giallongo C, Tibullo D, Camiolo G, Parrinello NL, Romano A, Puglisi F, Barbato A, Conticello C, Lupo G, Anfuso CD, Lazzarino G, Volti GL, Palumbo GA, Di Raimono F. Giallongo C, et al. Among authors: puglisi f. Cell Death Dis. 2019 Oct 28;10(11):820. doi: 10.1038/s41419-019-2059-2. Cell Death Dis. 2019. PMID: 31659155 Free PMC article.
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells.
Tibullo D, Giallongo C, Romano A, Vicario N, Barbato A, Puglisi F, Parenti R, Amorini AM, Wissam Saab M, Tavazzi B, Mangione R, Brundo MV, Lazzarino G, Palumbo GA, Volti GL, Raimondo FD, Lazzarino G. Tibullo D, et al. Among authors: puglisi f. Biomolecules. 2020 Apr 30;10(5):696. doi: 10.3390/biom10050696. Biomolecules. 2020. PMID: 32365811 Free PMC article.
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling.
Romano A, Parrinello NL, Simeon V, Puglisi F, La Cava P, Bellofiore C, Giallongo C, Camiolo G, D'Auria F, Grieco V, Larocca F, Barbato A, Cambria D, La Spina E, Tibullo D, Palumbo GA, Conticello C, Musto P, Di Raimondo F. Romano A, et al. Among authors: puglisi f. Sci Rep. 2020 Feb 6;10(1):1983. doi: 10.1038/s41598-020-58859-x. Sci Rep. 2020. PMID: 32029833 Free PMC article.
Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma.
Romano A, Parrinello NL, Chiarenza A, Motta G, Tibullo D, Giallongo C, La Cava P, Camiolo G, Puglisi F, Palumbo GA, Di Raimondo F. Romano A, et al. Among authors: puglisi f. Br J Haematol. 2019 May;185(3):468-479. doi: 10.1111/bjh.15801. Epub 2019 Feb 15. Br J Haematol. 2019. PMID: 30768678 Free article. Clinical Trial.
479 results